Home / Health / Breakthrough: Artificial Lens Treats Cataracts and Glaucoma
Breakthrough: Artificial Lens Treats Cataracts and Glaucoma
13 Oct
Summary
- Experimental lens delivers glaucoma medication during cataract surgery.
- Over 95% of patients needed no additional glaucoma medication after one year.
- Clinical trials show comparable eye pressure reduction to daily drops.
A new clinical trial has revealed promising results for an experimental cataract lens designed to also treat glaucoma. This artificial lens slowly releases a common glaucoma medication, bimatoprost, directly into the eye.
Researchers reported that after one year, patients receiving the innovative lens demonstrated comparable eye pressure levels to those using standard cataract lenses and regular glaucoma eyedrops. Notably, more than 95% of patients with the drug-releasing lens did not require any further glaucoma medication.
This development could simplify treatment for two prevalent eye diseases. Glaucoma, characterized by increasing eye pressure that damages the optic nerve, is typically managed with daily eyedrops, which can be difficult for patients to administer consistently.
The study, presented at the American Academy of Ophthalmology meeting, involved 106 patients. Larger follow-up trials are now underway to assess the long-term effectiveness and safety of this groundbreaking approach.
